Ceftolozane-tazobactam Versus Meropenem for Treatment of Nosocomial Pneumonia (ASPECT-NP): A Randomised, Controlled, Double-Blind, Phase 3, Non-Inferiority Trial

National ANTIBIOTIC RESISTANCE Portal

Home • Scientific literature watch • Ceftolozane-tazobactam Versus Meropenem for Treatment of Nosocomial Pneumonia (ASPECT-NP): A Randomised, Controlled, Double-Blind, Phase 3, Non-Inferiority Trial

A Decrease font size. A Reset font size. A Increase font size.

[acf:scientific_post_journal] • [acf:scientific_post_date]

, , ,

Clinical trial
International
Ceftolozane-tazobactam, Clinical trial, Drug therapy, Meropenem, Nosocomial Pneumonia

Cookies

This website uses cookies to improve your experience when browsing the website. Of these cookies, the cookies categorized as necessary are stored on your browser as they are essential for the functioning of basic website functionality. We also use third-party cookies which help us analyze and understand how you use this website. These cookies will only be stored in your browser with your consent. You also have the option of deactivating these cookies. But disabling some of these cookies may have an effect on your browsing experience.

Necessary

Always Enabled

Les cookies nécessaires sont absolument essentiels au bon fonctionnement du site Web. Cette catégorie comprend uniquement les cookies qui garantissent les fonctionnalités de base et les fonctionnalités de sécurité du site Web. Ces cookies ne stockent aucune information personnelle.

Cookie	Duration	Description
cookielawinfo-checkbox-necessary	11 mois	This cookie is set by the GDPR Cookie Consent plugin. Cookies are used to store user consent for cookies in the "Necessary" category.
cookielawinfo-checkbox-non-necessary	11 mois	This cookie is set by the GDPR Cookie Consent plugin. Cookies are used to store user consent for cookies in the "Not necessary" category.
cookielawinfo-checkbox-stats	1an	This cookie is set by the GDPR Cookie Consent plugin. The purpose of this cookie is to check whether or not the user has given his consent to the use of cookies in the “Statistics” category.
viewed_cookie_policy	11 mois	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not the user has consented to the use of cookies. It does not store any personal data.

Performance

Ils servent à collecter les informations sur l’utilisation du site, par exemple les pages que vous visitez, ou les messages d’erreur rencontrés. Ces cookies ne collectent aucune information permettant de vous identifier – toute l’information collectée est anonyme et n’est utilisée que dans le but d’améliorer le fonctionnement de notre site.

Cookie	Type	Duration	Description
_GPSLSC	0	4 minutes	This cookie is associated with a page speed script to improve the speed of the web page.

Statistics

Tous les cookies qui peuvent ne pas être particulièrement nécessaires au fonctionnement du site Web et qui sont utilisés spécifiquement pour collecter des données personnelles des utilisateurs via des analyses, des publicités et d’autres contenus intégrés sont appelés cookies non nécessaires. Il est obligatoire d’obtenir le consentement de l’utilisateur avant d’exécuter ces cookies sur votre site Web.

Cookie	Type	Duration	Description
_pk_id.1.8d15	0	1 an	This cookie makes it possible to track the click behavior of an anonymous visitor based on an identifier on the Piwik server. By using an identifier, we can link the different https requests together. It will be deleted after 1 year.
_pk_ses.1.8d15	0	30 minutes	This cookie is used to identify a unique visit for web statistics. Remains for 30 minutes after the cookie is placed or updated.
Matomo Analytics	third party	13 mois	Cookie allowing the tracking of your navigation on the site. It makes it possible to carry out analyzes and statistics on the use of the site by all visitors. This tracking does not contain confidential data and does not allow you to be identified.

Ceftolozane-tazobactam Versus Meropenem for Treatment of Nosocomial Pneumonia (ASPECT-NP): A Randomised, Controlled, Double-Blind, Phase 3, Non-Inferiority Trial

Upcoming events

10th Symposium on Antimicrobial Resistance in Animals and the Environment (ARAE) – Berlin, Germany

Annonce Congrès SFM 2025